BB
Insider
Bruce Booth
DirectorBruce Booth (Director) filed 16 Form 4 reports in the trailing twelve months (0 purchases, 16 sales, 1 filed past the two-business-day deadline), most often in Kymera Therapeutics, Inc. (KYMR). The largest single filing was $56.3M of KYMR (511,764 sh across 27 lots, as filed), executed Jun 26.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
16
0 buys · 16 sells · 1 late
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$246.6M
shares × price, as filed
Last traded
Jun 29
Filed Jul 2
Median ADV $102.3M across their filed names
Open performance→Volume by month
Buys $1.1M
Sells $246.6M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
16 filings
Sector per market data · by filing · past 12 months
Most traded names
KYMRRecent filings
KYMRSALE
Kymera Therapeutics, Inc.
View filing →
$8.2M75,750 sh across 12 lots
Exec Jun 29
Filed Jul 2 · 5:39 PM ET † KYMRSALE Kymera Therapeutics, Inc. View filing → $3.4M
31,126 sh across 7 lots
Exec Jun 29
Filed Jun 30 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $56.3M
511,764 sh across 27 lots
Exec Jun 26
Filed Jun 30 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $34.5M
283,553 sh across 16 lots
Exec Jun 25
Filed Jun 25 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $43.8M
396,626 sh across 22 lots
Exec Jun 23
Filed Jun 25 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $3.3M
31,798 sh across 4 lots
Exec Jun 22
Filed Jun 22 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $45.1M
476,201 sh across 26 lots
Exec Jun 17
Filed Jun 22 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $531K
5,900 sh × $89.96
Exec Apr 22
Filed Apr 24 · 5:30 PM ET More filings →